{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:18:22Z","timestamp":1789996702345,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG057557"],"award-info":[{"award-number":["AG057557"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG061388"],"award-info":[{"award-number":["AG061388"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG062272"],"award-info":[{"award-number":["AG062272"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UL1TR002548-01"],"award-info":[{"award-number":["1UL1TR002548-01"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interactions between the gut microbiota, microglia, and aging may modulate Alzheimer\u2019s disease (AD) pathogenesis but the precise nature of such interactions is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed an integrated multi-dimensional, knowledge-driven, systems approach to identify interactions among microbial metabolites, microglia, and AD. Publicly available datasets were repurposed to create a multi-dimensional knowledge-driven pipeline consisting of an integrated network of microbial metabolite\u2013gene\u2013pathway\u2013phenotype (MGPPN) consisting of 34,509 nodes (216 microbial metabolites, 22,982 genes, 1329 pathways, 9982 mouse phenotypes) and 1,032,942 edges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We evaluated the network-based ranking algorithm by showing that abnormal microglia function and physiology are significantly associated with AD pathology at both genetic and phenotypic levels: AD risk genes were ranked at the top 6.4% among 22,982 genes,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001. AD phenotypes were ranked at the top 11.5% among 9982 phenotypes,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001. A total of 8094 microglia\u2013microbial metabolite\u2013gene\u2013pathway\u2013phenotype\u2013AD interactions were identified for top-ranked AD-associated microbial metabolites. Short-chain fatty acids (SCFAs) were ranked at the top among prioritized AD-associated microbial metabolites. Through data-driven analyses, we provided evidence that SCFAs are involved in microglia-mediated gut\u2013microbiota\u2013brain interactions in AD at both genetic, functional, and phenotypic levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our analysis produces a novel framework to offer insights into the mechanistic links between gut microbial metabolites, microglia, and AD, with the overall goal to facilitate disease mechanism understanding, therapeutic target identification, and designing confirmatory experimental studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00917-1","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T13:47:54Z","timestamp":1634737674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Gut\u2013microbiota\u2013microglia\u2013brain interactions in Alzheimer\u2019s disease: knowledge-based, multi-dimensional characterization"],"prefix":"10.1186","volume":"13","author":[{"given":"QuanQiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela B.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu G.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Murali","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-4795","authenticated-orcid":false,"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"issue":"19","key":"917_CR1","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","volume":"80","author":"LE Hebert","year":"2013","unstructured":"Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census. Neurology. 2013;80(19):1778\u201383.","journal-title":"Neurology"},{"issue":"5","key":"917_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd2896","volume":"9","author":"M Citron","year":"2010","unstructured":"Citron M. Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov. 2010;9(5):387\u201398.","journal-title":"Nat Rev Drug Discov"},{"issue":"6086","key":"917_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262\u20137.","journal-title":"Science"},{"key":"917_CR4","doi-asserted-by":"crossref","unstructured":"Tremaroli V, B\u00e4ckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242.","DOI":"10.1038\/nature11552"},{"issue":"10","key":"917_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"917_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451\u201363.","journal-title":"Cell"},{"issue":"7573","key":"917_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/526312a","volume":"526","author":"PA Smith","year":"2015","unstructured":"Smith PA. The tantalizing links between gut microbes and the brain. Nat News. 2015;526(7573):312.","journal-title":"Nat News"},{"key":"917_CR8","doi-asserted-by":"crossref","unstructured":"Morais LH, Schreiber HL, Mazmanian SK. The gut microbiota\u2013brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19(4):241\u201355.","DOI":"10.1038\/s41579-020-00460-0"},{"issue":"1","key":"917_CR9","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep. 2017;7(1):13537.","journal-title":"Sci Rep"},{"issue":"4","key":"917_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L, et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2018;63(4):1337\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"917_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"N Saji","year":"2019","unstructured":"Saji N, Niida S, Murotani K, Hisada T, Tsuduki T, Sugimoto T, et al. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci Rep. 2019;9(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"1","key":"917_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S MahmoudianDehkordi","year":"2019","unstructured":"MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, et al. Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease\u2014an emerging role for gut microbiome. Alzheimers Dement. 2019;15(1):76\u201392.","journal-title":"Alzheimers Dement"},{"key":"917_CR13","doi-asserted-by":"crossref","unstructured":"Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, et al. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;78(2):683\u201397.","DOI":"10.3233\/JAD-200306"},{"issue":"10","key":"917_CR14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/nu9101053","volume":"9","author":"D Del Rio","year":"2017","unstructured":"Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F, et al. The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid. Nutrients. 2017;9(10):1053.","journal-title":"Nutrients"},{"issue":"1","key":"917_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13195-018-0451-2","volume":"10","author":"NM Vogt","year":"2018","unstructured":"Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, et al. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10(1):124.","journal-title":"Alzheimers Res Ther"},{"issue":"5-6","key":"917_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0197-0186(01)00040-7","volume":"39","author":"J Rogers","year":"2001","unstructured":"Rogers J, Lue LF. Microglial chemotaxis, activation, and phagocytosis of amyloid \u03b2-peptide as linked phenomena in Alzheimer\u2019s disease. Neurochem Int. 2001;39(5-6):333\u201340.","journal-title":"Neurochem Int"},{"issue":"10","key":"917_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21(10):1359\u201369.","journal-title":"Nat Neurosci"},{"key":"917_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fncel.2018.00488","volume":"12","author":"S Bachiller","year":"2018","unstructured":"Bachiller S, Jim\u00e9nez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, et al. Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Front Cell Neurosci. 2018;12:488.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"917_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/JAD-161149","volume":"57","author":"M Robinson","year":"2017","unstructured":"Robinson M, Lee BY, Hane FT. Recent progress in Alzheimer\u2019s disease research, part 2: genetics and epidemiology. J Alzheimers Dis. 2017;57(2):317\u201330.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"917_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, de Angelis ALH, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965.","journal-title":"Nat Neurosci"},{"issue":"7","key":"917_CR21","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nn.4051","volume":"18","author":"KI Mosher","year":"2015","unstructured":"Mosher KI, Wyss-Coray T. Go with your gut: microbiota meet microglia. Nat Neurosci. 2015;18(7):930.","journal-title":"Nat Neurosci"},{"issue":"9","key":"917_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrgastro.2015.127","volume":"12","author":"JF Cryan","year":"2015","unstructured":"Cryan JF, Dinan TG. Gut microbiota: microbiota and neuroimmune signaling\u2014Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol. 2015;12(9):494.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"917_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","volume":"121","author":"J Tan","year":"2014","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91\u2013119.","journal-title":"Adv Immunol"},{"issue":"10","key":"917_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/nu3100858","volume":"3","author":"MA Vinolo","year":"2011","unstructured":"Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3(10):858\u201376.","journal-title":"Nutrients"},{"issue":"1","key":"917_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/14737175.2018.1400909","volume":"18","author":"L Ho","year":"2018","unstructured":"Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer\u2019s disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother. 2018;18(1):83\u201390.","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"917_CR26","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2164-16-S7-S4","volume":"16","author":"R Xu","year":"2015","unstructured":"Xu R, Wang Q, Li L. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics. 2015;16(7):S4.","journal-title":"BMC Genomics"},{"issue":"3","key":"917_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12918-016-0307-y","volume":"10","author":"R Xu","year":"2016","unstructured":"Xu R, Wang Q. Towards understanding brain-gut-microbiome connections in Alzheimer\u2019s disease. BMC Syst Biol. 2016;10(3):63.","journal-title":"BMC Syst Biol"},{"issue":"1","key":"917_CR28","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1038\/s41598-018-24315-0","volume":"8","author":"Q Wang","year":"2018","unstructured":"Wang Q, Li L, Xu R. A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer. Sci Rep. 2018;8(1):6225.","journal-title":"Sci Rep"},{"issue":"1","key":"917_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12864-019-5510-y","volume":"20","author":"Q Wang","year":"2019","unstructured":"Wang Q, Xu R. Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis. BMC Genomics. 2019;20(1):124.","journal-title":"BMC Genomics"},{"issue":"D1","key":"917_CR30","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2017","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2017;46(D1):D608\u201317.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"917_CR31","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2015;44(D1):D380\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"917_CR32","doi-asserted-by":"publisher","first-page":"D801","DOI":"10.1093\/nar\/gky1056","volume":"47","author":"CJ Bult","year":"2018","unstructured":"Bult CJ, Blake JA, Smith CL, Kadin JA, Richardson JE. Mouse genome database (MGD) 2019. Nucleic Acids Res. 2018;47(D1):D801\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"917_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2017.328","volume":"37","author":"AB Nagaraj","year":"2018","unstructured":"Nagaraj AB, Wang QQ, Joseph P, Zheng C, Chen Y, Kovalenko O, et al. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment. Oncogene. 2018;37(3):403\u201314.","journal-title":"Oncogene"},{"issue":"3","key":"917_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ygyno.2018.09.019","volume":"151","author":"AB Nagaraj","year":"2018","unstructured":"Nagaraj AB, Joseph P, Kovalenko O, Wang QQ, Xu R, DiFeo A. Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Gynecol Oncol. 2018;151(3):525\u201332.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"917_CR35","first-page":"251","volume":"17","author":"Y Chen","year":"2016","unstructured":"Chen Y, Gao Z, Wang B, Xu R. Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes. BMC Genomics. 2016;17(7):251\u20137.","journal-title":"BMC Genomics"},{"key":"917_CR36","unstructured":"Chen Y, Cai X, Xu R. Combining human disease genetics and mouse model phenotypes towards drug repositioning for Parkinson\u2019s disease. In:  AMIA annual symposium proceedings (Vol. 2015). San Francisco: American Medical Informatics Association; 2015. p. 1851."},{"issue":"12","key":"917_CR37","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260.","journal-title":"Bioinformatics."},{"issue":"suppl_1","key":"917_CR38","first-page":"D767","volume":"37","author":"TS Keshava Prasad","year":"2008","unstructured":"Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, et al. Human protein reference database\u20142009 update. Nucleic Acids Res. 2008;37(suppl_1):D767\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"917_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/bioinformatics\/btw737","volume":"33","author":"Y Chen","year":"2016","unstructured":"Chen Y, Xu R. Context-sensitive network-based disease genetics prediction and its implications in drug discovery. Bioinformatics. 2016;33(7):1031\u20139.","journal-title":"Bioinformatics"},{"issue":"12","key":"917_CR40","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1093\/bioinformatics\/bty906","volume":"35","author":"M Zhou","year":"2018","unstructured":"Zhou M, Chen Y, Xu R. A drug-side effect context-sensitive network approach for drug target prediction. Bioinformatics. 2018;35(12):2100\u20137.","journal-title":"Bioinformatics"},{"key":"917_CR41","first-page":"1300","volume":"2018","author":"Q Wang","year":"2018","unstructured":"Wang Q, Xu R. Disease comorbidity-guided drug repositioning: a case study in schizophrenia. AMIA Annu Symp Proc. 2018;2018:1300\u20139.","journal-title":"AMIA Annu Symp Proc"},{"issue":"1","key":"917_CR42","first-page":"17","volume":"12","author":"Y Chen","year":"2019","unstructured":"Chen Y, Xu R. Context-sensitive network analysis identifies food metabolites associated with Alzheimer\u2019s disease: an exploratory study. BMC Med Genet. 2019;12(1):17.","journal-title":"BMC Med Genet"},{"issue":"Supplement_1","key":"917_CR43","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btaa451","volume":"36","author":"M Zhou","year":"2020","unstructured":"Zhou M, Zheng C, Xu R. Combining phenome-driven drug-target interaction prediction with patients\u2019 electronic health records-based clinical corroboration toward drug discovery. Bioinformatics. 2020;36(Supplement_1):i436\u201344. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa451.","journal-title":"Bioinformatics"},{"issue":"8","key":"917_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"917_CR45","unstructured":"Alzforum. Alzheimer\u2019s disease commonly used mouse models. https:\/\/www.alzforum.org\/research-models\/alzheimers-disease\/commonly-used (data Accessed in June 2020)."},{"issue":"suppl_1","key":"917_CR46","first-page":"D514","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33(suppl_1):D514\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"917_CR47","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2015","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2015;44(D1):D862\u20138. https:\/\/doi.org\/10.1093\/nar\/gkv1222.","journal-title":"Nucleic Acids Res"},{"key":"917_CR48","doi-asserted-by":"publisher","first-page":"ec329","DOI":"10.1126\/scisignal.aad8159","volume":"8","author":"LK Ferrarelli","year":"2015","unstructured":"Ferrarelli LK. Microglia spread tau. Sci Signal. 2015;8:ec329. https:\/\/doi.org\/10.1126\/scisignal.aad8159.","journal-title":"Sci Signal"},{"issue":"2","key":"917_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/13607863.2012.742488","volume":"17","author":"AK Piazza-Gardner","year":"2013","unstructured":"Piazza-Gardner AK, Gaffud TJ, Barry AE. The impact of alcohol on Alzheimer\u2019s disease: a systematic review. Aging Ment Health. 2013;17(2):133\u201346.","journal-title":"Aging Ment Health"},{"issue":"13","key":"917_CR50","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1096\/fj.06-6281com","volume":"20","author":"J Wang","year":"2006","unstructured":"Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, et al. Moderate consumption of Cabernet Sauvignon attenuates A neuropathology in a mouse model of Alzheimer\u2019s disease. FASEB J. 2006;20(13):2313\u201320.","journal-title":"FASEB J"},{"issue":"4","key":"917_CR51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clineuro.2005.06.005","volume":"108","author":"J Deng","year":"2006","unstructured":"Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen ME. A 2-year follow-up study of alcohol consumption and risk of dementia. Clin Neurol Neurosurg. 2006;108(4):378\u201383.","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"917_CR52","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/JGP.0b013e3181a2fd07","volume":"17","author":"KJ Anstey","year":"2009","unstructured":"Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17(7):542\u201355.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"917_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14727","volume":"8","author":"A Nobili","year":"2017","unstructured":"Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, et al. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat Commun. 2017;8(1):1\u201314.","journal-title":"Nat Commun"},{"key":"917_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","volume":"6","author":"A Martorana","year":"2014","unstructured":"Martorana A, Koch G. Is dopamine involved in Alzheimer\u2019s disease? Front Aging Neurosci. 2014;6:252.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"917_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","volume":"203","author":"D Storga","year":"1996","unstructured":"Storga D, Vrecko K, Birkmayer JGD, Reibnegger G. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci Lett. 1996;203(1):29\u201332.","journal-title":"Neurosci Lett"},{"issue":"7","key":"917_CR56","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/dneu.22716","volume":"79","author":"TJ Gross","year":"2019","unstructured":"Gross TJ, Doran E, Cheema AK, Head E, Lott IT, Mapstone M. Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer\u2019s disease. Dev Neurobiol. 2019;79(7):622\u201338.","journal-title":"Dev Neurobiol"},{"issue":"11","key":"917_CR57","doi-asserted-by":"publisher","first-page":"e13820","DOI":"10.1371\/journal.pone.0013820","volume":"5","author":"Y Xiang","year":"2010","unstructured":"Xiang Y, Xu G, Weigel-Van Aken KA. Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins. PLoS One. 2010;5(11):e13820.","journal-title":"PLoS One"},{"issue":"5","key":"917_CR58","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jn\/132.5.1012","volume":"132","author":"BF Hinnebusch","year":"2002","unstructured":"Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr. 2002;132(5):1012\u20137.","journal-title":"J Nutr"},{"issue":"1","key":"917_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nbt.3703","volume":"35","author":"S Magn\u00fasd\u00f3ttir","year":"2017","unstructured":"Magn\u00fasd\u00f3ttir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol. 2017;35(1):81\u20139.","journal-title":"Nat Biotechnol"},{"key":"917_CR60","doi-asserted-by":"publisher","first-page":"103524","DOI":"10.1016\/j.jbi.2020.103524","volume":"109","author":"Q Wang","year":"2020","unstructured":"Wang Q, Xu R. CoMNRank: an integrated approach to extract and prioritize human microbial metabolites from MEDLINE records. J Biomed Inform. 2020;109:103524. https:\/\/doi.org\/10.1016\/j.jbi.2020.103524 Epub 2020 Aug 11.","journal-title":"J Biomed Inform"},{"issue":"1","key":"917_CR61","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1038\/s41598-020-67075-6","volume":"10","author":"Q Wang","year":"2020","unstructured":"Wang Q, Xu R. Automatic extraction, prioritization and analysis of gut microbial metabolites from biomedical literature. Sci Rep. 2020;10(1):9996. https:\/\/doi.org\/10.1038\/s41598-020-67075-6.","journal-title":"Sci Rep"},{"issue":"1","key":"917_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou AG, Goate AM. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener. 2017;12(1):1\u20132.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"917_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"9","key":"917_CR64","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Investig. 2017;127(9):3240\u20139.","journal-title":"J Clin Investig"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00917-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T14:07:18Z","timestamp":1675778838000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00917-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00917-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no disclosures for other authors. MC is an employee of Tetra Therapeutics and owns shares. PMD has received research grants\/advisory fees from companies for other projects; PMD owns stock in health companies whose products are not discussed here; PMD is a co-inventor on unlicensed patents in this field; PMD serves on the health system and non-profit boards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}